Is it a possibility that this data came from another company which is interested in licensing RECAF? This would be a little competition for Abbott. Or did this data come from Abbott?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.